377 related articles for article (PubMed ID: 16671277)
1. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
[TBL] [Abstract][Full Text] [Related]
2. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
3. How to improve the safety of biologic therapy in Crohn's disease.
Ferkolj I
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
Feagan BG; Enns R; Fedorak RN; Panaccione R; Paré P; Steinhart AH; Wild G
Can J Clin Pharmacol; 2001; 8(4):188-98. PubMed ID: 11743591
[TBL] [Abstract][Full Text] [Related]
5. Toxicity of infliximab in the course of treatment of Crohn's disease.
Bratcher JM; Korelitz BI
Expert Opin Drug Saf; 2006 Jan; 5(1):9-16. PubMed ID: 16370952
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center].
Dotan I; Yeshurun D; Hallak A; Horowitz N; Tiomny E; Reif S; Halpern Z; Rachmilewitz D
Harefuah; 2001 Apr; 140(4):289-93, 368. PubMed ID: 11303390
[TBL] [Abstract][Full Text] [Related]
7. Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
Bourikas LA; Kourbeti IS; Koutsopoulos AV; Koutroubakis IE
Gut; 2008 Mar; 57(3):425; author reply 425-6. PubMed ID: 18268059
[No Abstract] [Full Text] [Related]
8. Guidelines for treatment with infliximab for Crohn's disease.
Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
[TBL] [Abstract][Full Text] [Related]
9. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease.
Vadikolias K; Kouklakis G; Heliopoulos I; Argyropoulou P; Papanas N; Tzilonidou M; Prassopoulos P; Piperidou H
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):159-62. PubMed ID: 17273002
[TBL] [Abstract][Full Text] [Related]
10. Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience.
Danese S; Colombel JF; Reinisch W; Rutgeerts PJ
Aliment Pharmacol Ther; 2011 Apr; 33(8):857-69. PubMed ID: 21320139
[TBL] [Abstract][Full Text] [Related]
11. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
[TBL] [Abstract][Full Text] [Related]
12. Psoriasiform and pustular eruption induced by infliximab.
Takahashi H; Hashimoto Y; Ishida-Yamamoto A; Ashida T; Kohgo Y; Iizuka H
J Dermatol; 2007 Jul; 34(7):468-72. PubMed ID: 17584325
[TBL] [Abstract][Full Text] [Related]
13. Timing infliximab therapy in pediatric Crohn's disease.
Kirschner BS; Huo D
Gastroenterology; 2007 Mar; 132(3):1167-70. PubMed ID: 17383435
[No Abstract] [Full Text] [Related]
14. Review article: Infliximab therapy for inflammatory bowel disease--seven years on.
Rutgeerts P; Van Assche G; Vermeire S
Aliment Pharmacol Ther; 2006 Feb; 23(4):451-63. PubMed ID: 16441465
[TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and treatment with infliximab.
Zhang Z; Correa H; Bégué RE
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859880
[No Abstract] [Full Text] [Related]
16. [Meningitis due to Listeria monocytogenes as a complication of infliximab therapy].
Joosten AA; van Olffen GH; Hageman G
Ned Tijdschr Geneeskd; 2003 Jul; 147(30):1470-2. PubMed ID: 12908351
[TBL] [Abstract][Full Text] [Related]
17. [A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].
Guyot A; Begon E; Abramowitz L; Landry J; Marinho E; Descamps V; Crickx B
Ann Dermatol Venereol; 2009 Nov; 136(11):806-10. PubMed ID: 19917434
[TBL] [Abstract][Full Text] [Related]
18. Infliximab: new indication. Severe Crohn's disease in children: many unknowns.
Prescrire Int; 2008 Aug; 17(96):145. PubMed ID: 19489184
[TBL] [Abstract][Full Text] [Related]
19. Infliximab therapy in Crohn's disease: safety issues.
Hommes DW; van Deventer SJ
Neth J Med; 2003 Apr; 61(4):100-4. PubMed ID: 12852717
[TBL] [Abstract][Full Text] [Related]
20. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
